About The Study: This study showed venous thromboembolism (VTE) risk variation across hormonal contraceptives with highest rates for combined pills, especially those containing third-generation progestins, and no significant difference in risk for intrauterine devices (IUDs) relative to no use. For patches and implants, the increased VTE risk was uncertain due to limited data. Variation in VTE risk across products underscores the importance of personalized contraceptive counseling.
Corresponding Author: To contact the corresponding author, Harman Gailan Hassan Yonis, MD, email harman@live.dk .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.28778)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.28778?guestAccessKey=41774d00-db7d-4abd-9029-9927cc186a45&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021025
JAMA